Rafferty Asset Management »

Miragen Therapeutics shares owned by Rafferty Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Rafferty Asset Management from 13F filings

Historical chart of Rafferty Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Rafferty Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 91k 22.75
2024-03-31 $7.2M 409k 17.51
2023-09-30 $4.0M 262k 15.34
2023-06-30 $5.8M 244k 23.79
2023-03-31 $4.5M 177k 25.44
2022-12-31 $3.4M 117k 29.21
2022-09-30 $1.2M 58k 20.50